Picture of Biomx logo

PHGE Biomx Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual income statement for Biomx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
June 30th
2019
December 31st
2019
June 30th
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Total Revenue00000
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses0.00122.20.40530.335.5
Operating Profit-0.001-22.2-0.405-30.3-35.5
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-0.001-20.60.483-30.1-36.2
Provision for Income Taxes
Net Income After Taxes-0.001-20.60.347-30.1-36.2
Net Income Before Extraordinary Items
Net Income-0.001-20.60.347-30.1-36.2
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-0.001-20.60.347-30.1-36.2
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.001-3.660.174-1.3-1.39
Dividends per Share

Or unlock with your email

Or unlock with your email